Alethia Young - Net Worth and Insider Trading
Alethia Young Net Worth
The estimated net worth of Alethia Young is at least $409,012 dollars as of 2024-11-29. Alethia Young is the Director of PTC Therapeutics Inc and owns about 9,067 shares of PTC Therapeutics Inc (PTCT) stock worth over $409,012. Details can be seen in Alethia Young's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alethia Young has not made any transactions after 2023-09-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alethia Young
Alethia Young Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alethia Young owns 4 companies in total, including Graphite Bio Inc (GRPH) , PTC Therapeutics Inc (PTCT) , and Bicycle Therapeutics PLC (BCYC) among others .
Click here to see the complete history of Alethia Young’s form 4 insider trades.
Insider Ownership Summary of Alethia Young
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRPH | Graphite Bio Inc | 2022-04-01 | Chief Financial Officer |
| PTCT | PTC Therapeutics Inc | 2023-09-06 | director |
| BCYC | Bicycle Therapeutics PLC | 2023-07-17 | Chief Financial Officer |
 | | 2023-10-06 | director |
Alethia Young Latest Holdings Summary
Alethia Young currently owns a total of 1 stock. Alethia Young owns 9,067 shares of PTC Therapeutics Inc (PTCT) as of September 6, 2023, with a value of $409,012.
Latest Holdings of Alethia Young
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PTCT | PTC Therapeutics Inc | 2023-09-06 | 9,067 | 45.11 | 409,012 |
Holding Weightings of Alethia Young
Alethia Young Form 4 Trading Tracker
According to the SEC Form 4 filings, Alethia Young has made a total of 1 transactions in PTC Therapeutics Inc (PTCT) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in PTC Therapeutics Inc is the sale of 11,666 shares on September 6, 2023, which brought Alethia Young around $465,007.
Insider Trading History of Alethia Young
- 1
Alethia Young Trading Performance
Alethia Young Ownership Network
Alethia Young Owned Company Details
What does Graphite Bio Inc do?
Who are the key executives at Graphite Bio Inc?
Alethia Young is the Chief Financial Officer of Graphite Bio Inc. Other key executives at Graphite Bio Inc include 10 percent owner Ecor1 Capital, Llc , 10 percent owner Samsara Biocapital, L.p. , and CHIEF BUSINESS OFFICER Phil Gutry .
Graphite Bio Inc (GRPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Graphite Bio Inc (GRPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Graphite Bio Inc (GRPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Graphite Bio Inc (GRPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Graphite Bio Inc Insider Transactions
Alethia Young Mailing Address
Above is the net worth, insider trading, and ownership report for Alethia Young. You might contact Alethia Young via mailing address: C/o Graphite Bio, Inc., 201 Haskins Way, Suite 210, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
